Skip to main content
SpringerLink
Log in

Effect of hepatic artery chemotherapy on survival of patients with hepatic metastases from colorectal carcinoma treated with cryotherapy

  • Original Scientific Reports
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Thirty-eight patients with unresectable multiple liver metastases from colorectal carcinoma were treated with either hepatic artery chemotherapy (HAC) and cryotherapy (n=27) or cryotherapy alone (n=11). Follow-up survival data were summarized using Cox regression. Allowing for the effect of the pathology of the primary tumor and the preoperative carcinoembryonic antigen (CEA) level, those patients who did not receive HAC after cytoreduction were three times as likely to die as those given HAC (RR 3.3, 95%; CI 1.2–9.3). The estimated median survival of patients treated with cryotherapy alone was 245 days, whereas for those given more than 3 months of HAC plus cytoreduction therapy it was 570 days. It is recommended that all patients who receive cryotherapy for multiple liver metastases from colorectal rectal carcinoma be given subsequent hepatic artery chemotherapy.

Résumé

Trente-huit patients ayant des métastases hépatiques multiples non reséquables d'origine colorectale ont été traités soit par chimiothérapie par voie artérielle (CVA) associée à la cryothérapie (n=27) soit par cryothérapie seule (n=11). Les survies ont été analysées selon la méthode d'analyse du Modèle de Cox. En tenant compte de l'effet de la pathologie de la tumeur primitive et du niveau préopératoire de l'ACE, les patients n'ayant pas eu de de décéder que ceux qui en ont eu (RR 3.3, 95% IC 12 à 9.3). L'estimation de la survie médiane des patients traités par la cytoréduction seule a été de 245 jours, alors que celle des patients traités par les deux avec une CVA d'au moins trois mois, a été de 570 jours. On recommande que tous les patients ayant des métastases multiples du foie à partir des cancers colorectaux aient une CVA par la suite.

Resumen

En el presente estudio, 38 pacientes con metástasis hepáticas múltiples y no resecables de carcinoma colo-rectal fueron tratados con quimioterapia administrada en la arteria hepática (HAC) y crioterapia (n=27) o crioterapia sola (n=11). Los datos del seguimiento fueron resumidos según el método de regresión de Cox. Teniendo en cuenta el efecto de la patología del tumor primario y el nivel preoperatorio de antígeno carcino-embrionario, se halló que aquellos pacientes que no recibieron HAC luego de la citorreducción tuvieron una probabilidad de muerte 3 veces mayor que los que recibieron HAC (RR 3.3, 95% CI 1.2 a 9.3). La sobrevida media estimada de los pacientes tratados con crioterapia sola fue de 245 días, en tanto que aquellos que recibieron HAC por tres meses y terapia de citorreducción fue de 570 días. Se recomienda que todos los pacientes que reciben crioterapia para metástasis hepáticas múltiples de carcinoma colo-rectal reciban luego quimioterapia por vía de la arteria hepática.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hughes, K., Scheele, J., Sugarbaker, P.H.: Surgery for colorectal cancer metastatic to the liver optimizing the results of treatment. Surg. Clin. North Am. 69:339, 1989

    Google Scholar 

  2. Scheele, J., Stangl, R., Altendorf-Hofman, A.: Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br. J. Surg. 77:1241, 1990

    Google Scholar 

  3. Jaffe, B.M., Donegan, W.L., Watson, F., Spratt, J.S.: Factors influencing survival in patients with untreated hepatic metastases. Surg. Gynecol. Obstet. 127:1, 1968

    Google Scholar 

  4. Bengtsson, G., Carlsson, G., Hafstrom, L.O., Jonsson, P.E.: Natural history of patients with untreated liver metastases from colorectal cancer. Am. J. Surg. 141:586, 1981

    Google Scholar 

  5. Hohn, D., Stagg, R., Friedman, M., et al.: A randomized trial of continous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. J. Clin. Oncol. 7:1646, 1989

    Google Scholar 

  6. Chang, A.E., Schneider, P.D., Sugarbaker, P.H.: A prospective randomized trial of regional versus systemic continous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann. Surg. 206:685, 1987

    Google Scholar 

  7. Martin, J.K., Jr. O'Connell, M.J., Wieand, H.S., et al.: Intra-arterial floxuridine versus systemic fluorouracil for hepatic metastases from colorectal cancer: a randomized trial. Arch. Surg. 125:1022, 1990

    Google Scholar 

  8. Rougier, P.H., Laplanche, A., Huguier, M., et al.: Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J. Clin. Oncol. 10:1112, 1992

    Google Scholar 

  9. Ravikumar, T.S., Kane, R., Cady, B.,et al. Hepatic cryotherapy with intraoperative ultrasound monitoring for metastatic colon carcinoma. Arch. Surg. 122:403, 1987

    Google Scholar 

  10. Zhou, X.D., Tang, Z.Y., Yu, Y-Q., Ma, Z-C.: Clinical evaluation of cryosurgery in the treatment of primary liver cancer. Cancer 197:375, 1988

    Google Scholar 

  11. Gilbert, J.C., Onik, G.M., Hoddick, W., Rubinsky, B.: Real time ultrasonic monitoring of hepatic cryosurgery. Cryobiology 22:319, 1985

    Google Scholar 

  12. Onik, G., Kane, R., Steele, G., et al.: Monitoring hepatic cryosurgery with sonography. A.J.R. Am. J. Roengenol. 147:665, 1986

    Google Scholar 

  13. Thomas, M., Morris, D.L., Hardcastle, J.D.: Contact ultrasound in the detection of liver metastases from colorectal cancer; an, in vitro study. Br. J. Surg. 74:955, 1987

    Google Scholar 

  14. Charnley, R.M., Morris, D.L., Dennison, A.R., Amar, S.S., Hardcastle, J.D.: Detection of colorectal liver metastases using intraoperative ultrasonography. Br. J. Surg. 78:45, 1991

    Google Scholar 

  15. Charnley, R.M., Thomas, M., Morris, D.L.: Effect of hepatic cryotherapy on serum CEA concentration in patients with multiple inoperable hepatic metastases from colorectal cancer. Aust. N.Z.J. Surg. 61:55, 1991

    Google Scholar 

  16. Onik, G., Rubinsky, B., Zemel, R., et al.: Ultrasound-guided hepatic cryosurgery in the treatment of metastatic colon carcinoma. Cancer 67:901, 1991

    Google Scholar 

  17. Ravikumar, T.S., Kane, R., Cady, B., et al.: A 5-year study of cryosurgery in the treatment of liver tumours. Arch. Surg. 126:1520, 1991

    Google Scholar 

  18. Dilley, A.V., Dy, D.Y., Warlters, A. et al.: Laboratory and animal model evaluation of the Cryotech, LCS 2000 in hepatic cryotherapy. Cryobiology 30:74, 1993

    Google Scholar 

  19. Goodie, D.B., Horton, M.D., Morris, R., Nagy, L.S., Morris, D.L.: The anaesthetic experience with hepatic cryotherapy for metastatic colonic carcinoma. Anaesthe. Intens. Care 20:491, 1992

    Google Scholar 

  20. Ardalan, B., Flores, M.G., Letter, J. Clin. Oncol. 11:384, 1993

    Google Scholar 

  21. Cox, D.R.: Regression models and life-tables J. R. Stat. Soc. [B] 34:187, 1972

    Google Scholar 

  22. Harrell, F.E., Lee, K.L.: Verifying assumptions of the Cox proportional hazards model. In Proceedings of the Eleventh Annual SAS Users Group International Conference, Atlanta, February 9–12, 1986 Cary, NC, SAS Institute, 1986, pp. 823–828

    Google Scholar 

  23. Kleinbaum, D.G., Kupper, L.L., Muller, K.E.: Applied Regression Analysis and Other Multivariate Methods, Boston, PWS-Kent, 1988

    Google Scholar 

  24. Kemeny, N.E.: Is hepatic infusion of chemotherapy effective treatment for liver metastases? Yes! In Important Advances in Oncology, 1992. V.T. De Vita, Jr., S. Hellmen, S.A. Rosenberg, editors, Philadelphia, Lippincott, 1992, pp. 207–227

    Google Scholar 

  25. Hunt, T.M., Flowerdew, A.D.S., Birch, S.J., et al.: Prospective randomized controlled trial of hepatic arterial embolization or infusion chemotherapy with 5-fluorouracil and degradable starch microspheres for colorectal liver metastases. Br. J. Surg. 77:779, 1990

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, University of New South Wales, The St. George Hospital, Belgrave Street, Kogarah, 2217, Sydney, New South Wales, Australia

    A. P. Preketes, J. King, W. B. Ross & D. L. Morris

  2. Department of Public Health, Sydney University, 2217, Sydney, New South Wales, Australia

    J. R. M. Caplehorn

  3. Cancer Care Centre, The St. George Hospital, Belgrave Street, Kogarah, 2217, Sydney, New South Wales, Australia

    P. R. Clingan

Authors
  1. A. P. Preketes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. R. M. Caplehorn
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. King
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. R. Clingan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. W. B. Ross
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D. L. Morris
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Preketes, A.P., Caplehorn, J.R.M., King, J. et al. Effect of hepatic artery chemotherapy on survival of patients with hepatic metastases from colorectal carcinoma treated with cryotherapy. World J. Surg. 19, 768–771 (1995). https://doi.org/10.1007/BF00295928

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00295928

Keywords

Search

Navigation